This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Philip Chun-Ying Wong: Pioneer in Alzheimer's Disease Research
Introduction
Philip Chun-Ying Wong, based in Timonium, Maryland, is an accomplished inventor known for his cutting-edge contributions to the field of Alzheimer's disease research. With one patent to his name, Wong has made significant strides in understanding the complexities of this debilitating condition.
Latest Patents
Wong's notable patent is titled "Transgenic mouse expressing non-native wild-type and familial Alzheimer's Disease mutant presenilin 1 protein on native presenilin 1 null background." This invention pertains to a transgenic non-human animal embryo that lacks native presenilin 1. The transgenic animals and cells derived from these embryos are pivotal for studying the expression pattern, activity, and modulators of presenilin 1. Furthermore, this innovation aids in the exploration of presenilin 1's role in Alzheimer's Disease and other disorders of the central nervous system.
Career Highlights
Throughout his career, Wong has become well-regarded in academic and research circles. His expertise in genetic engineering and neuroscience has positioned him as a key figure in investigating novel approaches to combat neurodegenerative diseases.
Collaborations
Wong has collaborated with esteemed colleagues Hui Zheng and Ping Jiang, contributing to a diverse array of research initiatives aimed at better understanding the mechanisms of Alzheimer's Disease. These collaborations highlight his commitment to advancing scientific knowledge through teamwork and shared expertise.
Conclusion
Philip Chun-Ying Wong continues to be an influential inventor and researcher, making invaluable contributions to the understanding of Alzheimer's disease. His innovations in transgenic technology not only pave the way for future research but also hold promise for the development of therapeutic strategies to combat this devastating illness.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile